Terms: = Endocrine gland cancer AND MEN1, ENSG00000133895, 4221 AND Diagnosis
460 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. [Multiple neuroendocrine tumors of the pancreas].
Sipos B
Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
[TBL] [Abstract] [Full Text] [Related]
3. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Early Diagnostic and Therapeutic Interventions and Clinical Course in Children and Adolescents with Multiple endocrine Neoplasia Types 1 and 2.
Kim JH; Lee Y; Hwang S; Yoon JH; Kim GH; Yoo HW; Choi JH
Exp Clin Endocrinol Diabetes; 2024 Jan; 132(1):39-46. PubMed ID: 37973156
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Case Report of Non-Diabetic Hypoglycemia Due to a Combination of Germline Mutations in the
Yukina M; Solodovnikova E; Popov S; Zakharova V; Utkina M; Petrov V; Troshina E; Mokrysheva N
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895301
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Factors Predicting Multiple endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
[TBL] [Abstract] [Full Text] [Related]
7. The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the
Vroonen L; Beckers A; Camby S; Cuny T; Beckers P; Jaffrain-Rea ML; Cogne M; Naves L; Ferriere A; Romanet P; Elenkova A; Karhu A; Brue T; Barlier A; Pétrossians P; Daly AF
Front Endocrinol (Lausanne); 2023; 14():1242588. PubMed ID: 37711900
[TBL] [Abstract] [Full Text] [Related]
8. Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes.
Jellins T; Hill M; Prager JD; Francom CR; Chan CM; Schneider KW; Sharma A; Herrmann BW
Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111703. PubMed ID: 37604101
[TBL] [Abstract] [Full Text] [Related]
9. Cutaneous lesions and other non-endocrine manifestations of Multiple endocrine Neoplasia type 1 syndrome.
Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
[TBL] [Abstract] [Full Text] [Related]
10. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
11. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract] [Full Text] [Related]
12. INSULINOMA OF THE TAIL OF THE PANCREAS - A CASE REPORT.
Mucha A; Pavlevska E; Jovanoska B; Milenkovik T; Bitoska I; Jovanovska S
Georgian Med News; 2023 May; (338):104-107. PubMed ID: 37419481
[TBL] [Abstract] [Full Text] [Related]
13. Traits of Patients With Pituitary Tumors in Multiple endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract] [Full Text] [Related]
14. Changes in diagnosis and operative treatment of insulinoma over two decades.
Wiese D; Humburg FG; Kann PH; Rinke A; Luster M; Mahnken A; Bartsch DK
Langenbecks Arch Surg; 2023 Jun; 408(1):255. PubMed ID: 37386194
[TBL] [Abstract] [Full Text] [Related]
15. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
16. [Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].
Mogl MT; Goretzki PE
Chirurgie (Heidelb); 2023 Jul; 94(7):586-594. PubMed ID: 37291366
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple endocrine Neoplasia Type 1 Syndrome.
Verschuur AVD; Kok ASM; Morsink FHM; de Leng WWJ; van den Broek MFM; Koudijs MJ; Offerhaus JA; Valk GD; Vriens MR; van Nesselrooij BPM; Hackeng WM; Brosens LAA
Am J Surg Pathol; 2023 Jul; 47(7):785-791. PubMed ID: 37199453
[TBL] [Abstract] [Full Text] [Related]
18. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
[TBL] [Abstract] [Full Text] [Related]
19. Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
[TBL] [Abstract] [Full Text] [Related]
20. Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms.
Herring BR; Bonner A; Guenter RE; Vickers S; Yates C; Lee G; Dhall D; Chen H; Rose JB
Cancer Res Commun; 2022 Oct; 2(10):1162-1173. PubMed ID: 36969744
[TBL] [Abstract] [Full Text] [Related]
[Next]
